Advocacy Group Presents Urgent Case to FDA on Opioid Crisis and Patient Care: Listening to People in Pain!
In a recent development that could mark a turning point in the opioid crisis, patient advocates briefed senior U.S. Food and Drug Administration (FDA) officials on July 23, 2024, regarding critical issues in the regulation of prescription opioid painkillers. The presentation, titled “The Real Opioid Crisis in Three Charts,” challenged existing narratives surrounding opioid use […]
Continue Reading